{
  "as_of": "2026-10-23",
  "state": "AK",
  "name": "Alaska",
  "status": "not-covered",
  "statusLabel": "Not covered for obesity alone",
  "effective": "2026-09-18",
  "effectiveWhat": "criteria updated",
  "note": "Weight control is a non-covered use by regulation (7 AAC 105.110). Wegovy for MASH or heart risk, Zepbound for sleep apnea.",
  "source": {
    "title": "Alaska Medicaid clinical criteria, semaglutide and tirzepatide, updated 09/18/2026",
    "url": "https://health.alaska.gov/media/khdibtdl/semaglutide_criteria.pdf"
  },
  "read": "2026-10-23",
  "url": "https://kymatahealth.com/telehealth/glp1-coverage-map",
  "page": "https://kymatahealth.com/telehealth/glp1-coverage-map/alaska",
  "cite": "https://kymatahealth.com/telehealth/glp1-coverage-map/alaska"
}